About
Omniose develops a recombinant plasminogen-based regenerative therapy to promote healing of chronic wounds, particularly diabetic foot ulcers, by restarting the stalled natural healing process.
Explore Omniose's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.